Company 5 DiaMedica Therapeutics Inc. (NASDAQ:
Post# of 32129
![Avatar](/images/ProfileImages/1996739806_13310_Entertained 3.jpg)
DiaMedica Therapeutics Inc.
(NASDAQ
![](/images/icons/icon_biggrin.gif)
![](/images/icons/icon_biggrin.gif)
Market Cap: $42M
Revenue: "we are an early stage company with no approved products and no revenue"
Announced pricing, approval and uplisted all on the same day.
DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING
https://globenewswire.com/news-release/2018/1...STING.html
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)